AI, Welfare & Long-term Care News ・ 🧠 Dementia care

AI Prioritises Alzheimer’s Drug Candidates but Clinical Translation Remains Unproven

Bioengineer.org 🔗 Share link 11/11 04:00 UTC 🔗 Share link Machine Learning Evaluates Dementia-Friendly Architectural Sightlines in Early Building Layouts — Bioengineer.org · 11/11 06:40 UTC

Artificial intelligence now nominates a substantial share of Alzheimer's disease pipeline candidates. The description states that translating computational drug repurposing into clinical efficacy requires rigorous testing.

Read the original (Bioengineer.org 🔗 Share link 11/11 04:00 UTC 🔗 Share link Machine Learning Evaluates Dementia-Friendly Architectural Sightlines in Early Building Layouts — Bioengineer.org)

See it in the digest → ・ See this issue →